Search Results - "Koskela, Sirpa"
-
1
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
Published in Haematologica (Roma) (01-07-2023)“…The BCL-2 inhibitor venetoclax has revolutionized the treatment of acute myeloid leukemia (AML) in patients not benefiting from intensive chemotherapy…”
Get full text
Journal Article -
2
Coagulopathy in Acute Puumala Hantavirus Infection
Published in Viruses (06-08-2021)“…Puumala hantavirus (PUUV) causes a hemorrhagic fever with renal syndrome (HFRS), also called nephropathia epidemica (NE), which is mainly endemic in Europe and…”
Get full text
Journal Article -
3
Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection
Published in PloS one (11-11-2015)“…Hantavirus infections are characterized by both activation and dysfunction of the endothelial cells. The underlying mechanisms of the disease pathogenesis are…”
Get full text
Journal Article -
4
Diminished coagulation capacity assessed by calibrated automated thrombography during acute Puumala hantavirus infection
Published in Blood coagulation & fibrinolysis (01-01-2018)“…Coagulation abnormalities are associated with Puumala-virus-induced hemorrhagic fever with renal syndrome (PUUV–HFRS). We evaluated the coagulation capacity of…”
Get full text
Journal Article -
5
P562: CAPILLARY BLOOD SAMPLING ALLOWS FEASIBLE METHOD FOR VENETOCLAX CONCENTRATION MEASUREMENT IN AN ACADEMIC MULTICENTER CLINICAL TRIAL CONTEXT
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
6
Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia
Published in Blood coagulation & fibrinolysis (01-09-2014)“…Thrombocytopenia and altered coagulation characterize all hantavirus infections. To further assess the newly discovered predictive biomarkers of disease…”
Get full text
Journal Article -
7
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial
Published in Blood (02-10-2024)“…The BCL2 inhibitor venetoclax has shown promise for treating acute myeloid leukemia (AML). However, identifying patients likely to respond remains a challenge,…”
Get full text
Journal Article -
8
Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax + Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial
Published in Blood (23-11-2021)“…Background BCL-2 inhibitor venetoclax (Ven) in combination with azacitidine (Aza) has substantially improved overall response rates (ORR) and overall survival…”
Get full text
Journal Article -
9
Ex Vivo Venetoclax Sensitivity Testing Predicts Response and Overall Survival in De Novo and s/R/R AML Patients Treated with Azacitidine and Venetoclax
Published in Blood (15-11-2022)Get full text
Journal Article -
10
Spleen enlargement is a common finding in acute Puumala hantavirus infection and it does not associate with thrombocytopenia
Published in Scandinavian journal of infectious diseases (01-10-2014)“…Abstract The pathogenesis of thrombocytopenia in Puumala hantavirus (PUUV) infection is probably multifactorial. We aimed to evaluate the possible spleen…”
Get full text
Journal Article -
11
Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant
Published in Infectious diseases (London, England) (01-02-2015)“…Abstract Early identification of patients at risk of a severe course of hantaviral disease and lack of effective medication represent a global challenge in the…”
Get full text
Journal Article -
12
Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection: e0142872
Published in PloS one (01-11-2015)“…Introduction Hantavirus infections are characterized by both activation and dysfunction of the endothelial cells. The underlying mechanisms of the disease…”
Get full text
Journal Article -
13
Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant
Published in Infectious Diseases (01-02-2015)“…Early identification of patients at risk of a severe course of hantaviral disease and lack of effective medication represent a global challenge in the…”
Get full text
Report